(Q57471075)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

title

Removing the Mask of Average Treatment Effects in Chronic Lyme Disease Research Using Big Data and Subgroup Analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

3

Jennifer Mankoff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

author name string

Mira Shapiro

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

language of work or name

English

0 references

publication date

12 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

28 April 2020

copyright license

start time

12 October 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

12 December 2020

Lyme disease: an infectious and postinfectious syndrome.

1 reference

12 December 2020

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study.

1 reference

12 December 2020

Clinical and serologic follow-up in patients with neuroborreliosis

1 reference

12 December 2020

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease

1 reference

12 December 2020

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

1 reference

12 December 2020

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial

1 reference

12 December 2020

Assessment of reflux symptom severity: methodological options and their attributes

1 reference

12 December 2020

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

1 reference

12 December 2020

Economic impact of Lyme disease

1 reference

12 December 2020

1 reference

12 December 2020

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

1 reference

12 December 2020

Responsiveness of measures of heartburn improvement in non-erosive reflux disease

1 reference

12 December 2020

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

1 reference

12 December 2020

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

1 reference

12 December 2020

In the era of systematic reviews, does the size of an individual trial still matter

1 reference

12 December 2020

Statistics in brief: the importance of sample size in the planning and interpretation of medical research

1 reference

12 December 2020

Diagnostic challenges of early Lyme disease: lessons from a community case series

1 reference

12 December 2020

Gender bias in chronic lyme disease.

1 reference

12 December 2020

Global rating of change scales: a review of strengths and weaknesses and considerations for design

1 reference

12 December 2020

Bartonellosis, an increasingly recognized zoonosis

1 reference

12 December 2020

Sex differences in the clinical and serologic presentation of early Lyme disease: Results from a retrospective review

1 reference

12 December 2020

Baseline dependency of minimal clinically important improvement.

1 reference

12 December 2020

Healthcare access and burden of care for patients with Lyme disease: a large United States survey

1 reference

12 December 2020

Misdiagnosis of early Lyme disease as the summer flu

1 reference

12 December 2020

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

1 reference

12 December 2020

Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials

1 reference

12 December 2020

1 reference

12 December 2020

Development of a foundation for a case definition of post-treatment Lyme disease syndrome

1 reference

12 December 2020

Bringing big data to personalized healthcare: a patient-centered framework

1 reference

12 December 2020

Clinimetrics corner: a closer look at the minimal clinically important difference (MCID).

1 reference

12 December 2020

The state of infectious diseases clinical trials: a systematic review of ClinicalTrials.gov

1 reference

12 December 2020

Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey

1 reference

12 December 2020

Patient-powered research networks aim to improve patient care and health research

1 reference

12 December 2020

Assessing the value of patient-generated data to comparative effectiveness research

1 reference

12 December 2020

Detection of Bartonella species in the blood of veterinarians and veterinary technicians: a newly recognized occupational hazard?

1 reference

12 December 2020

Emerging uses of patient generated health data in clinical research

1 reference

12 December 2020

Health care costs, utilization and patterns of care following Lyme disease

1 reference

12 December 2020

U.S. public's experience with ticks and tick-borne diseases: Results from national HealthStyles surveys.

1 reference

12 December 2020

Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials

1 reference

12 December 2020

Integrating Patient-Generated Health Data Into Clinical Care Settings or Clinical Decision-Making: Lessons Learned From Project HealthDesign

1 reference

12 December 2020

Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence

1 reference

12 December 2020

From Evidence Based Medicine to Medicine Based Evidence

1 reference

12 December 2020

Global rating of change: perspectives of patients with lumbar impairments and of their physical therapists

1 reference

12 December 2020

Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study.

1 reference

12 December 2020

Inverting the patient involvement paradigm: defining patient led research.

1 reference

12 December 2020

10.3390/HEALTHCARE6040124

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30322049%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference